NEW YORK (GenomeWeb News) – SDIX, formerly Strategic Diagnostics, today reported that its first-quarter 2010 revenues dipped 3 percent, though its life science sales were up 3 percent year over year.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.